Human immunodeficiency virus type 1 polymerase messenger RNA (HIV-1 pol mRNA)

Human immunodeficiency virus type 1 polymerase messenger RNA (HIV-1 pol mRNA) is a critical viral transcript that encodes the essential enzymes required for the replication and maturation of HIV-1. These enzymes, including protease, reverse transcriptase, and integrase, are translated from the pol gene as part of a Gag-Pol polyprotein via a unique -1 ribosomal frameshifting mechanism (Jacks et al., 1988, Nature). Because these enzymes are indispensable for converting the viral RNA genome into DNA and integrating it into the host cell's genome, the pol mRNA is a high-priority target for preventing viral proliferation (Coffin et al., 1997, Retroviruses). Therapeutic strategies targeting this mRNA include antisense oligonucleotides, small interfering RNAs (siRNAs), and ribozymes, which are designed to bind specifically to the pol sequence and induce its degradation or block its translation (Rossi et al., 1991, Pharmacological Therapeutics). This approach is particularly valuable because it can simultaneously halt the production of all three key viral enzymes, potentially offering a higher genetic barrier to resistance than traditional small-molecule inhibitors (Surabhi & Rossi, 2002, Gene Therapy). However, the high mutation rate of HIV-1 and the challenge of delivering nucleic acid therapies to latently infected cells remain significant obstacles to clinical success (Castanotto & Rossi, 2009, Nature).

Other names

HIV-1 pol transcriptHIV-1 polymerase mRNAHIV-1 gag-pol mRNAPol gene mRNA

RNA interference (RNAi), antisense-mediated RNase H degradation, and ribozyme-mediated catalytic cleavage of viral RNA.